Error 3: Too aggressive titration The problem: "I am jumping from 0.5 mg directly to 4 mg," which almost certainly leads to severe side effects such as extreme nausea
We, who are endocrinologists, cardiologists, and nephrologists, know well the efficacy of GLP-1 receptor agonist (GLP-1 RA) therapy in weight loss and improving cardiovascular diseases risk factors
This is the most important unknown in the current data
Is it the decreased inflammation from a significant weight loss
For individuals at this life stage, a provider may consider a more gradual titration approach based on individual clinical factors
PlexusDx providers work with your primary care physician to coordinate your full medication plan, ensuring semaglutide complements rather than substitutes for cholesterol-lowering therapy